glucosamine has been researched along with Obesity in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (20.69) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 11 (37.93) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Cazzola, R; Cestaro, B; Della Porta, M; Gasparri, C; Lombardoni, F; Nichetti, M; Patelli, Z; Perna, S; Pistolesi, E; Rondanelli, M | 1 |
| Cho, H; Han, IO; Hwang, JS; Nam, MS; Park, JW | 1 |
| Aagaard, KM; Chu, DM; Cox, JE; Gonzalez-Rodriguez, PJ; Goodspeed, DM; Krannich, LA; Seferovic, MD | 1 |
| Cao, P; Chen, J; Ding, C; Guo, J; Huang, L; Pan, H; Su, Z; Xiao, T; Zhang, P | 1 |
| Ballesteros, F; Blas, JR; Camacho, W; Castañeda, O; Chico, A; Coimbra, I; Duarte, M; Espinosa, R; Esquivel, JA; Felipe, OJ; Garcia, AK; Gil, ML; Guibert, M; Gutierrez, CE; Iraheta, I; Molina, JF; Muñoz Louis, R; Papasidero, S; Quintero, M; Radrigan, F; Reginato, AM; Reveille, J; Riera, H; Rillo, O; Rossi, C; Souto, R; Torres, AR; Urioste, L; Vera, M | 1 |
| Bierma-Zeinstra, SM; de Vos, BC; Oei, EH; Runhaar, J; van Middelkoop, M; Vroegindeweij, D | 1 |
| Bierma-Zeinstra, SMA; Gommans, YMM; Jacobs, ML; Runhaar, J | 1 |
| Barrientos, C; Quevedo, L; Racotta, R | 1 |
| Horowitz, M; Lee, A; Morley, JE; Patrick, P; Wishart, J | 1 |
| Fischer, S; Hanefeld, M | 1 |
| Boies, SM; Olefsky, JM; Yu, JG | 1 |
| Haslbeck, M; Jakob, S; Kellerer, M; Linn, T | 1 |
| García-Lorda, P; Laferrère, B; Pi-Sunyer, FX; Russell, CD | 1 |
| Bondy, CA; Carter, SD; Clegg, PD; Goggs, R; Innes, JF; Mobasheri, A; Schwab, W; Shakibaei, M; Vaughan-Thomas, A | 1 |
| Bronstein, JA; Crandon, SK; Hall, G; Hortin, GL; Karne, RJ; Muniyappa, R; Quon, MJ; Ver, MR | 1 |
| Barry, K; Bianco, AC; Crunkhorn, S; da Silva, WS; Dearie, F; Espinoza, D; Faucette, R; Gami, H; Mantzoros, C; Patti, ME | 1 |
| Tuma, DJ; Vanderhoof, JA | 1 |
| DeBouno, JF; Michaelis, OE; Tulp, OL | 1 |
| Axen, KV; Li, X; Sclafani, A | 1 |
| Dolphin, PJ; Graham, SE; Russell, JC | 1 |
| Ambrosius, WT; Considine, RV; Cooksey, RC; Fawcett, RL; Huse, J; Inman, M; Jones, R; McClain, DA; Whitfield, RM; Williams, LB; Zhang, P | 1 |
| Cooksey, RC; Crook, ED; Daniels, MC; Hebert, LF; Hoffman, RT; McClain, DA; Tang, J; Veerababu, G | 1 |
| Barzilai, N; Cases, JA; Gabriely, I; Ma, XH; Rossetti, L; Yang, XM | 1 |
| DeBouno, JF; Michaelis, OE; Szepesi, B; Tulp, OL | 1 |
| Federlin, K; Hillebrand, I; Laube, H | 1 |
| Luger, A; Röggla, G; Schernthaner, G; Schnack, C | 1 |
| Hellman, B; Idahl, LA; Lernmark, A; Sehlin, J; Täljedal, IB | 1 |
| Hellman, B; Sehlin, J; Täljedal, IB | 1 |
| Blickens, DA; Riggi, SJ | 1 |
2 review(s) available for glucosamine and Obesity
| Article | Year |
|---|---|
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Carbamates; Contraindications; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Fasting; Follow-Up Studies; Germany; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Insulin; Metformin; Middle Aged; Nateglinide; Obesity; Patient Compliance; Phenylalanine; Pioglitazone; Piperidines; Practice Guidelines as Topic; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors | 2003 |
Nutraceutical therapies for degenerative joint diseases: a critical review.
Topics: Amino Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bivalvia; Camellia sinensis; Cartilage; Chondroitin Sulfates; Fatty Acids, Essential; Flavonoids; Glucosamine; Glucose; Humans; Nutritional Status; Obesity; Osteoarthritis; Osteochondritis Dissecans; Phenols; Polyphenols; Trace Elements; Vitamins | 2005 |
4 trial(s) available for glucosamine and Obesity
| Article | Year |
|---|---|
A Randomized Double-Blind Placebo-Controlled Clinical Study to Evaluate the Effect on the Weight of a Medical Device with Polyglucosamine L112 in a Group of Overweight and Obese Subjects.
Topics: Cholesterol; Glucosamine; Humans; Insulin Resistance; Obesity; Overweight; Vitamins; Weight Loss | 2023 |
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
Topics: 1-Deoxynojirimycin; Adult; Aged; Appetite; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Middle Aged; Obesity; Peptide Fragments; Postprandial Period; Protein Precursors | 2002 |
Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects.
Topics: Administration, Oral; Adult; Ascorbic Acid; Blood Pressure; Diabetes Mellitus, Type 1; Endothelium, Vascular; Glucosamine; Heart Rate; Humans; Insulin Resistance; Obesity; Reference Values; Thinness | 2006 |
Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.
Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Middle Aged; Obesity; Pancreatic Hormones | 1986 |
23 other study(ies) available for glucosamine and Obesity
| Article | Year |
|---|---|
Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet.
Topics: 3T3-L1 Cells; Animals; Cell Line, Tumor; Diet; Diet, High-Fat; Dietary Fats; Glucosamine; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; Weight Gain | 2015 |
Heritable IUGR and adult metabolic syndrome are reversible and associated with alterations in the metabolome following dietary supplementation of 1-carbon intermediates.
Topics: Animal Nutritional Physiological Phenomena; Animals; Animals, Newborn; Body Weight; Citric Acid; Dietary Supplements; Dyslipidemias; Female; Fetal Growth Retardation; Gas Chromatography-Mass Spectrometry; Glucosamine; Glucose Intolerance; Male; Metabolic Syndrome; Metabolome; Metabolomics; Obesity; Rats, Sprague-Dawley; Weaning | 2015 |
Anti-obese effect of glucosamine and chitosan oligosaccharide in high-fat diet-induced obese rats.
Topics: Adipocytes; Animals; Anti-Obesity Agents; Body Weight; Cell Differentiation; Chitosan; Cholesterol; Diet, High-Fat; Glucosamine; Lipoproteins, LDL; Liver X Receptors; Male; Obesity; Oligosaccharides; Orphan Nuclear Receptors; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2015 |
Osteoarthritis in Latin America: Study of Demographic and Clinical Characteristics in 3040 Patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthrography; Comorbidity; Cross-Sectional Studies; Demography; Female; Glucosamine; Humans; Hypertension; Latin America; Male; Middle Aged; Obesity; Osteoarthritis; Severity of Illness Index; Viscosupplements | 2015 |
Prevention of Incident Knee Osteoarthritis by Moderate Weight Loss in Overweight and Obese Females.
Topics: Body Weight; Diet, Reducing; Exercise Therapy; Female; Glucosamine; Humans; Middle Aged; Obesity; Osteoarthritis, Knee; Overweight; Risk Factors; Treatment Outcome; Weight Loss | 2016 |
The Effect of Prolonged Glucosamine Usage on HbA1c Levels and New-Onset Diabetes Mellitus in Overweight and Obese Middle-Aged Women.
Topics: Diabetes Mellitus; Dietary Supplements; Female; Glucosamine; Glycated Hemoglobin; Humans; Middle Aged; Obesity; Osteoporosis; Overweight; Risk Factors | 2017 |
Glucosamine attenuates increases of intraabdominal fat, serum leptin levels, and insulin resistance induced by a high-fat diet in rats.
Topics: Animals; Blood Glucose; Body Weight; Diet; Dietary Fats; Fatty Acids, Nonesterified; Glucosamine; Glucose Tolerance Test; Insulin; Insulin Resistance; Intra-Abdominal Fat; Leptin; Male; Obesity; Rats; Rats, Wistar; Weight Loss | 2010 |
[Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes].
Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Glucosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Resistance; Insulin Secretion; Metformin; Obesity; Pioglitazone; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Time Factors | 2003 |
The effect of oral glucosamine sulfate on insulin sensitivity in human subjects.
Topics: Blood Glucose; Glucosamine; Humans; Insulin; Obesity; Thinness | 2003 |
Effect of oral glucosamine sulfate on serum leptin levels in human subjects.
Topics: Administration, Oral; Adolescent; Adult; Blood Glucose; Dexamethasone; Dose-Response Relationship, Drug; Fasting; Glucosamine; Humans; Insulin Resistance; Leptin; Obesity | 2004 |
Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation.
Topics: Adipose Tissue; Amino Acids; Animals; Cell Line; Citric Acid Cycle; Dietary Fats; Enzyme Activation; Gene Expression Regulation; Glucosamine; Glucose; Histone Deacetylases; Hypoglycemic Agents; Insulin; MAP Kinase Signaling System; Mice; Mice, Obese; Mitochondrial Proteins; Muscle Fibers, Skeletal; Obesity; Oxidative Phosphorylation; p38 Mitogen-Activated Protein Kinases; Palmitic Acid; RNA, Messenger; Sweetening Agents; Time Factors; Transcription Factors; Transcription, Genetic | 2007 |
Hepatic protein synthesis and secretion after jejunoileal bypass in the rat.
Topics: Animals; Blood Proteins; Energy Intake; Glucosamine; Glycoproteins; Ileum; In Vitro Techniques; Jejunum; Leucine; Liver; Obesity; Protein Biosynthesis; Proteins; Rats; Rats, Inbred Strains; Triglycerides | 1983 |
The effects of the intestinal glucosidase inhibitory BAY M 1099 (miglitol) on glycemic status of obese-diabetic rats.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Male; Obesity; Rats; Rats, Inbred SHR | 1993 |
Miglitol (BAY m 1099) treatment of diabetic hypothalamic-dietary obese rats improves islet response to glucose.
Topics: 1-Deoxynojirimycin; Animal Feed; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Glucosamine; Glucose; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Rats; Rats, Sprague-Dawley; Ventromedial Hypothalamic Nucleus | 1999 |
Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Body Weight; Disease Models, Animal; Eating; Enzyme Inhibitors; Glucosamine; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Resistance; Lipids; Male; Obesity; Postprandial Period; Rats | 1999 |
Hexosamines regulate leptin production in human subcutaneous adipocytes.
Topics: Adipocytes; Body Mass Index; Cells, Cultured; Diazooxonorleucine; Glucosamine; Hexosamines; Humans; In Vitro Techniques; Leptin; Obesity; Stimulation, Chemical; Uridine Diphosphate N-Acetylglucosamine | 2000 |
Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance.
Topics: Adenosine Triphosphate; Animals; Fatty Acids, Nonesterified; Glucosamine; Glucose Intolerance; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycogen; Glycogen Synthase; Hyperlipidemias; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Phosphoenolpyruvate Carboxykinase (GTP); Phosphorylases; Reference Values; Triglycerides; Uridine Diphosphate N-Acetylgalactosamine | 2000 |
Hyperglycemia modulates angiotensinogen gene expression.
Topics: Adipose Tissue; Angiotensinogen; Animals; Blood Glucose; Body Composition; Body Weight; Gene Expression Regulation; Glucosamine; Glucose Clamp Technique; Hexosamines; Hyperglycemia; Hyperinsulinism; Infusions, Intravenous; Insulin; Insulin Resistance; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley | 2001 |
The effects of low-dose Bay-m-1099 (Miglitol) on serum lipids and liver enzyme activity of obese and obese-diabetic corpulent rats.
Topics: 1-Deoxynojirimycin; Adipose Tissue; Animals; Blood Glucose; Blood Proteins; Diabetes Mellitus; Glucokinase; Glucosamine; Glucosephosphate Dehydrogenase; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Insulin; Lipids; Liver; Obesity; Phenotype; Rats; Weight Gain | 1991 |
Effect of alpha-inhibitors on blood glucose and insulin levels.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Middle Aged; Obesity; Reference Values; Trisaccharides | 1988 |
The pancreatic beta-cell recognition of insulin secretagogues. Comparisons of glucose with glyceraldehyde isomers and dihydroxyacetone.
Topics: Acetone; Animals; Arginine; Calcium; Carbon Radioisotopes; Dinitrophenols; Epinephrine; Female; Glucosamine; Glucose; Glyburide; Glyceraldehyde; Insulin; Insulin Secretion; Iodoacetates; Islets of Langerhans; Isomerism; Leucine; Male; Obesity; Phlorhizin; Theophylline; Time Factors | 1974 |
Transport of 3-O-methyl-D-glucose into mammalian pancreatic -cells.
Topics: Animals; Biological Transport, Active; Carbon Isotopes; Cell Membrane; Glucosamine; Glucose; Heptoses; Hyperglycemia; Islets of Langerhans; Mannitol; Mice; Obesity; Phloretin; Phlorhizin; Sucrose | 1973 |
Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin.
Topics: Animals; Blood Glucose; Carbamates; Carbohydrate Metabolism; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Fasting; Glucosamine; Glycogen; Glycosuria; Guinea Pigs; Hyperglycemia; Hypoglycemia; Lactates; Liver Glycogen; Male; Mice; Nitroso Compounds; Obesity; Oxazoles; Phenformin; Pyridinium Compounds; Rats | 1971 |